130 related articles for article (PubMed ID: 3558706)
1. The "constant intake rate" assumption in interim recruitment goal methodology for multicenter clinical trials.
Williford WO; Bingham SF; Weiss DG; Collins JF; Rains KT; Krol WF
J Chronic Dis; 1987; 40(4):297-307. PubMed ID: 3558706
[TBL] [Abstract][Full Text] [Related]
2. Predictive event modelling in multicenter clinical trials with waiting time to response.
Anisimov VV
Pharm Stat; 2011; 10(6):517-22. PubMed ID: 22140055
[TBL] [Abstract][Full Text] [Related]
3. Bayesian optimal interval design for dose finding in drug-combination trials.
Lin R; Yin G
Stat Methods Med Res; 2017 Oct; 26(5):2155-2167. PubMed ID: 26178591
[TBL] [Abstract][Full Text] [Related]
4. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
Lachin JM
Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
[TBL] [Abstract][Full Text] [Related]
5. A Bayesian predictive sample size selection design for single-arm exploratory clinical trials.
Teramukai S; Daimon T; Zohar S
Stat Med; 2012 Dec; 31(30):4243-54. PubMed ID: 22807115
[TBL] [Abstract][Full Text] [Related]
6. Using Poisson-gamma model to evaluate the duration of recruitment process when historical trials are available.
Minois N; Lauwers-Cances V; Savy S; Attal M; Andrieu S; Anisimov V; Savy N
Stat Med; 2017 Oct; 36(23):3605-3620. PubMed ID: 28608361
[TBL] [Abstract][Full Text] [Related]
7. Bayesian hypothesis testing in two-arm trials with dichotomous outcomes.
Zaslavsky BG
Biometrics; 2013 Mar; 69(1):157-63. PubMed ID: 23002906
[TBL] [Abstract][Full Text] [Related]
8. Predictive probability methods for interim monitoring in clinical trials with longitudinal outcomes.
Zhou M; Tang Q; Lang L; Xing J; Tatsuoka K
Stat Med; 2018 Jun; 37(14):2187-2207. PubMed ID: 29664214
[TBL] [Abstract][Full Text] [Related]
9. Interim analyses in clinical trials: classical vs. Bayesian approaches.
Berry DA
Stat Med; 1985; 4(4):521-6. PubMed ID: 4089353
[TBL] [Abstract][Full Text] [Related]
10. Interim recruitment prediction for multi-center clinical trials.
Urbas S; Sherlock C; Metcalfe P
Biostatistics; 2022 Apr; 23(2):485-506. PubMed ID: 32978616
[TBL] [Abstract][Full Text] [Related]
11. Modeling time-varying recruitment rates in multicenter clinical trials.
Perperoglou A; Zhang Y; Kipourou DK
Biom J; 2023 Aug; 65(6):e2100377. PubMed ID: 36287068
[TBL] [Abstract][Full Text] [Related]
12. The Bayesian principle: can we adapt?
Berry DA
Stroke; 2005 Jul; 36(7):1623-4. PubMed ID: 15947273
[No Abstract] [Full Text] [Related]
13. Bayesian interim analysis in clinical trials.
Zhang X; Cutter G
Contemp Clin Trials; 2008 Sep; 29(5):751-5. PubMed ID: 18589003
[TBL] [Abstract][Full Text] [Related]
14. A time-dependent Poisson-Gamma model for recruitment forecasting in multicenter studies.
Turchetta A; Savy N; Stephens DA; Moodie EEM; Klein MB
Stat Med; 2023 Oct; 42(23):4193-4206. PubMed ID: 37491664
[TBL] [Abstract][Full Text] [Related]
15. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.
Daimon T
Contemp Clin Trials; 2008 Jul; 29(4):507-16. PubMed ID: 18201944
[TBL] [Abstract][Full Text] [Related]
16. Bayesian approach to noninferiority trials for proportions.
Gamalo MA; Wu R; Tiwari RC
J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
[TBL] [Abstract][Full Text] [Related]
17. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
Lewis RJ; Lipsky AM; Berry DA
Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
[TBL] [Abstract][Full Text] [Related]
18. Bayesian and non-Bayesian methods of inference.
Small RD; Schor SS
Ann Intern Med; 1983 Dec; 99(6):857-9. PubMed ID: 6360005
[No Abstract] [Full Text] [Related]
19. Optimal designs for estimating the interesting part of a dose-effect curve.
Miller F; Guilbaud O; Dette H
J Biopharm Stat; 2007; 17(6):1097-115. PubMed ID: 18027219
[TBL] [Abstract][Full Text] [Related]
20. Strategies for including patients recruited during interim analysis of clinical trials.
Faldum A; Hommel G
J Biopharm Stat; 2007; 17(6):1211-25. PubMed ID: 18027227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
